| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 8.725 | 13.412 | 12.564 | 15.669 | 20.059 |
| Total Income - EUR | - | - | - | - | - | 8.725 | 13.412 | 12.564 | 15.669 | 20.863 |
| Total Expenses - EUR | - | - | - | - | - | 1.372 | 5.888 | 9.306 | 10.868 | 17.992 |
| Gross Profit/Loss - EUR | - | - | - | - | - | 7.353 | 7.524 | 3.258 | 4.802 | 2.871 |
| Net Profit/Loss - EUR | - | - | - | - | - | 7.213 | 7.186 | 2.851 | 3.536 | 2.421 |
| Employees | - | - | - | - | - | 1 | 1 | 0 | 1 | 1 |
Check the financial reports for the company - Kerekesmed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 0 | 2.298 | 1.761 | 17.116 | 41.806 |
| Current Assets | - | - | - | - | - | 7.585 | 10.173 | 14.135 | 1.536 | 4.731 |
| Inventories | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | 0 | 0 | 60 | 60 | 3.875 |
| Cash | - | - | - | - | - | 7.585 | 10.173 | 14.075 | 1.476 | 855 |
| Shareholders Funds | - | - | - | - | - | 7.254 | 12.151 | 15.040 | 18.530 | 20.848 |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | 331 | 350 | 957 | 673 | 26.238 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Kerekesmed S.r.l.